CYTK - Cytokinetics, Incorporated

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201712/31/201612/31/201512/31/2014
Total Revenue13,368106,40728,65846,940
Cost of Revenue90,29664,39746,39844,426
Gross Profit-76,92842,010-17,7402,514
Operating Expenses
Research Development----
Selling General and Administrative36,46827,82319,66717,268
Non Recurring----
Others----
Total Operating Expenses126,76492,22066,06561,694
Operating Income or Loss-113,39614,187-37,407-14,754
Income from Continuing Operations
Total Other Income/Expenses Net-14,3942,266-94108
Earnings Before Interest and Taxes-113,39614,187-37,407-14,754
Interest Expense-16,996-2,698-268-268
Income Before Tax-127,79016,453-37,501-14,646
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-127,79016,453-37,501-14,646
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-127,79016,453-37,501-14,646
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-127,79016,453-37,501-14,646